158 related articles for article (PubMed ID: 23053185)
21. An atypical (b3/a3) junction of the bcr/abl gene lacking abl exon a2 in a patient with chronic myeloid leukemia.
Amabile M; Martinelli G; Terragna C; Montefusco V; Tabilio A; Tura S
Haematologica; 1999 Jun; 84(6):573-5. PubMed ID: 10366813
[No Abstract] [Full Text] [Related]
22. Targeting primary human leukaemia cells with RNA interference: Bcr-Abl targeting inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells.
Withey JM; Marley SB; Kaeda J; Harvey AJ; Crompton MR; Gordon MY
Br J Haematol; 2005 May; 129(3):377-80. PubMed ID: 15842662
[TBL] [Abstract][Full Text] [Related]
23. Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more.
Cea M; Cagnetta A; Garuti A; Cirmena G; Rocco I; Moran E; Grillo V; Ballestrero A; Patrone F; Nencioni A
J BUON; 2009; 14(4):565-73. PubMed ID: 20148444
[TBL] [Abstract][Full Text] [Related]
24. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
[No Abstract] [Full Text] [Related]
25. [Study on relationship between different bcr/abl fusion transcripts and clinical manifestations in chronic myeloid leukemia].
Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Qiu JY; Lu DP; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):347-50. PubMed ID: 12941187
[TBL] [Abstract][Full Text] [Related]
26. Chronic myeloid leukemia--advances in biology and new approaches to treatment.
Goldman JM; Melo JV
N Engl J Med; 2003 Oct; 349(15):1451-64. PubMed ID: 14534339
[No Abstract] [Full Text] [Related]
27. Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia.
Loncarevic IF; Römer J; Starke H; Heller A; Bleck C; Ziegler M; Fiedler W; Liehr T; Clement JH; Claussen U
Genes Chromosomes Cancer; 2002 Jun; 34(2):193-200. PubMed ID: 11979553
[TBL] [Abstract][Full Text] [Related]
28. Can morphological assessment limit the use of specific genetic testing to exclude chronic myeloid leukaemia?
So CC; Wan TS; Yip SF; Ma SK; Lam CC; Chan LC
Br J Haematol; 2007 May; 137(4):377. PubMed ID: 17374140
[No Abstract] [Full Text] [Related]
29. Imatinib mesylate resistance in a chronic myeloid leukemia patient with a novel e8a2 BCR-ABL transcript variant.
Qin YZ; Jiang B; Jiang Q; Zhang Y; Jiang H; Li JL; Zhu HH; Li LD; Liu YR; Chen SS; Huang XJ
Acta Haematol; 2008; 120(3):146-9. PubMed ID: 19039205
[TBL] [Abstract][Full Text] [Related]
30. [Chronic myelogenous leukemia expressing two bcr-abl chimeric mRNA; a case report].
Hashimoto S; Hiyoshi M; Hino M; Yamane T; Ota T; Koh KR; Tagawa S; Tatsumi N
Rinsho Ketsueki; 1997 Jan; 38(1):72-4. PubMed ID: 9028165
[TBL] [Abstract][Full Text] [Related]
31. Detection of BCR/ABL fusion gene in CML: a preliminary report.
Rerkamnuaychoke B; Kangwanpong D; Jootar S; Puranakanitstha C
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():197-200. PubMed ID: 8629106
[TBL] [Abstract][Full Text] [Related]
32. Clinical use of the bcr/abl probe test in the evaluation of chronic myeloid leukemia patients.
Yazici H; Sengün Z; Aktan M; Aktuglu G; Uskent N; Dalay N
J Exp Clin Cancer Res; 1997 Mar; 16(1):105-9. PubMed ID: 9148870
[TBL] [Abstract][Full Text] [Related]
33. P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?
Melo JV; Myint H; Galton DA; Goldman JM
Leukemia; 1994 Jan; 8(1):208-11. PubMed ID: 8289491
[TBL] [Abstract][Full Text] [Related]
34. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
35. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
[TBL] [Abstract][Full Text] [Related]
36. Identification of e19a2 BCR-ABL fusions (mu-BCR breakpoints) at the DNA level by ligation-mediated PCR.
Boeckx N; Jansen MW; Haskovec C; Vandenberghe P; van der Velden VH; van Dongen JJ
Leukemia; 2005 Jul; 19(7):1292-5. PubMed ID: 15843824
[No Abstract] [Full Text] [Related]
37. Differences and similarities in kinetics of BCR-ABL transcript levels in CML patients treated with imatinib mesylate for chronic or accelerated disease phase.
Moravcová J; Zmeková V; Klamová H; Voglová J; Faber E; Michalová K; Rabasová J; Jarosová M
Leuk Res; 2004 Apr; 28(4):415-9. PubMed ID: 15109543
[TBL] [Abstract][Full Text] [Related]
38. Synthetic small interfering RNAs reduce bcr-abl gene expression in leukaemic cells of de novo Philadelphia(+) acute myeloid leukaemia.
Koldehoff M; Steckel NK; Beelen DW; Elmaagacli AH
Clin Exp Med; 2006 Mar; 6(1):45-7. PubMed ID: 16550344
[No Abstract] [Full Text] [Related]
39. Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C.
Müller MC; Gattermann N; Lahaye T; Deininger MW; Berndt A; Fruehauf S; Neubauer A; Fischer T; Hossfeld DK; Schneller F; Krause SW; Nerl C; Sayer HG; Ottmann OG; Waller C; Aulitzky W; le Coutre P; Freund M; Merx K; Paschka P; König H; Kreil S; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2003 Dec; 17(12):2392-400. PubMed ID: 14523462
[TBL] [Abstract][Full Text] [Related]
40. Possible correlation between fusion pattern of BCR/ABL mRNA and clinical response to alpha-interferon in chronic myelogenous leukemia.
Inoue T; Tojo A; Tsuchimoto D; Okamoto S; Ogura H; Tani K; Ozawa K; Shibuya M; Asano S
Leukemia; 1992 Sep; 6(9):948-51. PubMed ID: 1518306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]